About: Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer (en) Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer (nl)
skos:prefLabel	Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer (en) Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer (nl)
name	Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer (en) Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer (nl)
title	wds:Q65332562-3D2E192F-593A-4E00-8F62-BA09598C6B44
title	A Pilot Study of Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Resectable or Potentially Resectable Pancreatic Adenocarcinoma (PDAC) (en)
end time	wds:Q65332562-44277CA7-AEC5-4C3B-9C56-48AE515F80C5
end time	2023-08-09 00:00:00Z (xsd:dateTime)
instance of	wds:Q65332562-FF41574F-0AAE-405A-AC30-CC6EE81CF3B3
instance of	clinical trial
start time	wds:Q65332562-C9746042-0878-4B2E-9762-E6330C57E122
start time	2016-01-01 00:00:00Z (xsd:dateTime)
country	wds:Q65332562-0A3E12F3-9CB4-4694-A931-4738C717466F
country	United States of America
main subject	wds:Q65332562-C0C5052D-7F41-4D60-99EA-86D37C721F55
main subject	resectable hepatocellular carcinoma
research intervention	wds:Q65332562-50432CDC-D0AE-4E4A-82D1-35273082B0E5 wds:Q65332562-E849B192-421C-412F-95E5-4A8256B844BF
research intervention	wd:Q423762 cisplatin
minimum age	wds:Q65332562-B348CB68-72A7-486D-963A-D1CC91B9D459
minimum age	18 (xsd:decimal)
medical condition	wds:Q65332562-A7967546-919E-4763-9FBB-B6F412EAB983
medical condition	adenocarcinoma
number of participants	wds:Q65332562-91693413-1E80-4823-9C4C-348961DE4EA3
number of participants	20 (xsd:decimal)
study type	wds:Q65332562-6B0F0203-A10A-4BCA-853B-208F94CB7865
study type	interventional study
ClinicalTrials.gov ID	wds:Q65332562-AA25A665-A62A-472B-A593-5754BA7C5DEF
ClinicalTrials.gov ID	NCT02550327
clinical trial phase	wds:Q65332562-3B6EA429-9AE9-4C15-968C-877AA29E2EC0
clinical trial phase	phase I clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65332562

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software